Innate Pharma SA 6-K Filing
Ticker: IPHA · Form: 6-K · Filed: Apr 3, 2026 · CIK: 0001598599
Sentiment: neutral
Filing Stats: 161 words · 1 min read · ~1 pages · Grade level 9.7 · Accepted 2026-04-03 07:02:06
Filing Documents
- a6k-iphx260403.htm (6-K) — 8KB
- exhibit991-260403.htm (EX-99.1) — 12KB
- 0001628280-26-023471.txt ( ) — 21KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. INNATE PHARMA S.A. Date Friday April 3, 2026 By s JONATHAN DICKINSON Name Jonathan Dickinson Title Chief Executive Officer